论文部分内容阅读
对于刚作出帕金森氏病诊断的患者之处理,尚有分歧意见:(1)是否需要立即处理;(2)首选药物问题;(3)左旋多巴的剂量问题。有人主张一旦作出诊断,就该立即治疗,应首选左旋多巴(加脱羧酶抑制剂),并至最大耐受量;认为失神经过敏为引起药物性多动症的重要因素,早期处理可推迟纹状体内失神经过敏之发展。但目前较普遍之意见为:不应在作出诊断时就给药物治疗,并首选左旋多巴;因从10年
There are different opinions on the treatment of patients who have just made a diagnosis of Parkinson’s disease: (1) whether immediate treatment is required; (2) the drug of choice; and (3) the dose of levodopa. Some people advocate that once diagnosed, the immediate treatment should be the preferred levodopa (plus decarboxylase inhibitors), and to the maximum tolerated; that denervation is an important factor in drug-induced ADHD, early treatment can delay the stria The development of denervation in the body. However, the more common opinion is that drug therapy should not be given at the time of diagnosis, and levodopa is the preferred choice. Since 10 years